Walgreens Boots Alliance, Inc. (WBA) announced on Wednesday the introduction of its own more affordable version of the over-the-counter opioid overdose reversal spray, naloxone.
The newly launched product, Walgreens Brand Naloxone HCl Nasal Spray, aims to mitigate the opioid crisis by enhancing the accessibility of this critical medication. It will be available online immediately and in all store locations by the end of the month.
Designed to temporarily counteract the effects of opioids during an overdose, this naloxone spray is effective against substances like heroin, illicit fentanyl, and prescription opioid drugs. The medication works by blocking opioid receptors in the brain, restoring normal breathing, and ultimately preventing fatality.
While naloxone is effective, its limited availability has intensified the opioid epidemic's impact in many communities. In response, Walgreens is offering its naloxone at a reduced price compared to the national brand, increasing its accessibility. Priced at $34.99, the Walgreens Brand Naloxone HCl Nasal Spray can be purchased online immediately, with nationwide in-store availability by month's end. Customers will find it conveniently located in the pain relief aisle, providing an essential lifeline for the millions Walgreens serves daily across the U.S.
The Centers for Disease Control and Prevention endorse naloxone as safe for bystander administration during suspected overdoses, noting it poses no risk if the individual is not actually overdosing. Walgreens' initiative to make naloxone more accessible holds significant potential in saving lives and curbing the opioid epidemic.
This proactive step by Walgreens could have a profound impact on public health, addressing one of the most pressing health crises in the United States today.
